Shanghai Yizhong Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Shanghai Yizhong Pharmaceutical has a total shareholder equity of CN¥1.5B and total debt of CN¥44.0M, which brings its debt-to-equity ratio to 3%. Its total assets and total liabilities are CN¥1.6B and CN¥108.5M respectively. Shanghai Yizhong Pharmaceutical's EBIT is CN¥159.6M making its interest coverage ratio -4.7. It has cash and short-term investments of CN¥1.2B.
Key information
3.0%
Debt to equity ratio
CN¥44.03m
Debt
Interest coverage ratio | -4.7x |
Cash | CN¥1.24b |
Equity | CN¥1.46b |
Total liabilities | CN¥108.52m |
Total assets | CN¥1.57b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 688091's short term assets (CN¥1.4B) exceed its short term liabilities (CN¥104.0M).
Long Term Liabilities: 688091's short term assets (CN¥1.4B) exceed its long term liabilities (CN¥4.5M).
Debt to Equity History and Analysis
Debt Level: 688091 has more cash than its total debt.
Reducing Debt: 688091's debt to equity ratio has increased from 0% to 3% over the past 5 years.
Debt Coverage: 688091's debt is well covered by operating cash flow (196.6%).
Interest Coverage: 688091 earns more interest than it pays, so coverage of interest payments is not a concern.